Insider Selling: Phibro Animal Health (NASDAQ:PAHC) CEO Sells 38,303 Shares of Stock

Phibro Animal Health Corporation (NASDAQ:PAHC) CEO Jack Bendheim sold 38,303 shares of the company’s stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $45.29, for a total transaction of $1,734,742.87. Following the completion of the transaction, the chief executive officer owned 20,577 shares of the company’s stock, valued at approximately $931,932.33. This trade represents a 65.05% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

Jack Bendheim also recently made the following trade(s):

• On Friday, November 7th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $42.86, for a total transaction of $150,867.20.
• On Tuesday, November 4th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The shares were sold at an average price of $43.10, for a total transaction of $151,712.00.
• On Thursday, October 30th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The shares were sold at an average price of $41.07, for a total value of $144,566.40.
• On Tuesday, October 28th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $41.56, for a total transaction of $146,291.20.
• On Thursday, October 23rd, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The shares were sold at an average price of $40.18, for a total value of $141,433.60.
• On Wednesday, October 22nd, Jack Bendheim sold 11,859 shares of Phibro Animal Health stock. The stock was sold at an average price of $40.27, for a total transaction of $477,561.93.
• On Monday, October 20th, Jack Bendheim sold 16,075 shares of Phibro Animal Health stock. The shares were sold at an average price of $40.38, for a total value of $649,108.50.
• On Friday, October 17th, Jack Bendheim sold 700 shares of Phibro Animal Health stock. The stock was sold at an average price of $40.03, for a total value of $28,021.00.
• On Thursday, September 18th, Jack Bendheim sold 7,022 shares of Phibro Animal Health stock. The shares were sold at an average price of $40.26, for a total value of $282,705.72.
• On Wednesday, September 10th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $41.29, for a total transaction of $145,340.80.

Phibro Animal Health Stock Performance

PAHC stock traded up $2.07 on Monday, hitting $45.83. The company’s stock had a trading volume of 462,658 shares, compared to its average volume of 278,152. The firm has a 50 day moving average of $39.89 and a two-hundred day moving average of $31.24. Phibro Animal Health Corporation has a 1 year low of $16.16 and a 1 year high of $46.42. The company has a current ratio of 2.76, a quick ratio of 1.25 and a debt-to-equity ratio of 2.46. The stock has a market cap of $1.86 billion, a price-to-earnings ratio of 38.84, a price-to-earnings-growth ratio of 1.24 and a beta of 0.81.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings results on Wednesday, November 5th. The company reported $0.73 earnings per share for the quarter, topping analysts’ consensus estimates of $0.58 by $0.15. Phibro Animal Health had a return on equity of 32.14% and a net margin of 3.73%.The company had revenue of $363.89 million for the quarter, compared to analyst estimates of $345.44 million. Phibro Animal Health has set its FY 2026 guidance at 2.640-2.810 EPS. Equities analysts predict that Phibro Animal Health Corporation will post 1.95 EPS for the current fiscal year.

Phibro Animal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, December 17th. Shareholders of record on Wednesday, November 26th will be given a dividend of $0.12 per share. The ex-dividend date of this dividend is Wednesday, November 26th. This represents a $0.48 dividend on an annualized basis and a yield of 1.0%. Phibro Animal Health’s dividend payout ratio is presently 28.92%.

Wall Street Analyst Weigh In

PAHC has been the subject of a number of research reports. Weiss Ratings raised Phibro Animal Health from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, November 5th. JPMorgan Chase & Co. lifted their price objective on Phibro Animal Health from $45.00 to $50.00 and gave the stock an “overweight” rating in a report on Friday. Bank of America lifted their price objective on shares of Phibro Animal Health from $19.00 to $27.00 and gave the company an “underperform” rating in a report on Friday, August 29th. Morgan Stanley set a $34.00 price objective on Phibro Animal Health in a research report on Thursday, August 28th. Finally, Zacks Research raised Phibro Animal Health from a “hold” rating to a “strong-buy” rating in a report on Monday, September 29th. One research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, three have assigned a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, Phibro Animal Health presently has an average rating of “Hold” and a consensus target price of $31.40.

Institutional Investors Weigh In On Phibro Animal Health

Hedge funds and other institutional investors have recently made changes to their positions in the business. EverSource Wealth Advisors LLC boosted its stake in Phibro Animal Health by 55.6% during the 3rd quarter. EverSource Wealth Advisors LLC now owns 4,233 shares of the company’s stock valued at $171,000 after purchasing an additional 1,513 shares during the period. Advisors Preferred LLC acquired a new stake in shares of Phibro Animal Health in the third quarter valued at about $3,953,000. Citigroup Inc. lifted its position in shares of Phibro Animal Health by 112.3% in the 3rd quarter. Citigroup Inc. now owns 54,941 shares of the company’s stock worth $2,223,000 after acquiring an additional 29,066 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management increased its holdings in shares of Phibro Animal Health by 27.7% during the third quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 14,720 shares of the company’s stock worth $596,000 after buying an additional 3,190 shares in the last quarter. Finally, Jupiter Asset Management Ltd. acquired a new stake in Phibro Animal Health in the third quarter worth about $228,000. Hedge funds and other institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.